Vaccine development for pathogenic fungi: current status and future directions

Area of Science:

• * Mycology and Immunology
• * Infectious Diseases and Vaccinology

Background:

• * Fungal infections pose a global health threat with high mortality and limited therapeutic options.
• * Existing antifungal medications are few, and no effective antifungal vaccine is currently available.
• * Research is actively pursuing new antifungal drugs, drug repurposing, and vaccine development.

Purpose of the Study:

• * To review and summarize the latest advancements in fungal vaccine research.
• * To outline various vaccine strategies currently under investigation for fungal pathogens.
• * To identify challenges hindering the clinical availability of antifungal vaccines.

Main Methods:

• * A comprehensive literature search was conducted on PubMed.
• * Keywords included 'fungal vaccines' and specific genera of fungal pathogens (e.g., *Cryptococcus*, *Candida*, *Aspergillus*).
• * A total of 177 relevant articles were collected and analyzed.

Main Results:

• * Several vaccine approaches are being explored, including subunit, whole organism, and DNA vaccines.
• * Optimization of adjuvant use is a key area of study in enhancing vaccine efficacy.
• * The review covers vaccine development for a range of significant fungal pathogens.

Conclusions:

• * No antifungal vaccines are currently approved for clinical use.
• * Challenges include difficulties in eliciting immune responses in immunocompromised individuals and the similarity between fungal and host cells.
• * Increased attention from health organizations is needed to address the burden of fungal infections.